Published Year: 2024
Digital Diagnostics Market - A Global and Regional Analysis: Focus on Application, Product, End User
The global digital diagnostics market is projected to reach $8,319.2 million by 2033 from...
Market Research Report
A quick peek into the report
Mass Spectrometry and Chromatography in Diagnostics Market Report Coverage
|
Mass Spectrometry and Chromatography in Diagnostics Market |
|||
|
Base Year |
2023 |
Market Size in 2023 |
$743.1 Million |
|
Forecast Period |
2024-2033 |
Value Projection and Estimation by 2033 |
$1,863.8 Million |
|
CAGR During Forecast Period |
9.92% |
Number of Pages |
199 |
| Number of Tables | 156 |
Number of Figures |
40 |
Key Market Players and Competition Synopsis
The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
The mass spectrometry and chromatography in diagnostics market (by product type) dominates by mass spectrometry and chromatography segment, securing a share of 85.34% in 2023. Sample preparation, on the other hand, accounted for approximately 14.66% of the market share in 2023.
Some prominent names established in this market are:
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Tecan Group Ltd.
• Danaher Corporation
• Shimadzu Corporation
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Promega Corporation
• Restek Corporation
• Gerstel GmbH & Co. KG
• Phenomenex Inc. (Danaher Corporation)
• Bruker Corporation
• New England Biolabs
• Hamilton Company
• Avantor, Inc. (VWR International, LLC.)
• Chromsystems Instruments & Chemicals GmbH
• RECIPE Chemicals + Instruments GmbH
• Zivak
• SENTINEL CH. SpA
Global Mass Spectrometry and Chromatography in Diagnostics Market Industry Overview
Introduction of Mass Spectrometry and Chromatography in Diagnostics Market
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% between 2024 and 2033. The mass spectrometry (MS) and chromatography markets are critical components of the broader analytical and life sciences instrumentation sector. Both technologies offer sophisticated methods for the separation, identification, and quantification of chemical and biological substances and have been instrumental in driving advances across a variety of fields, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, among others. For diagnostics applications, these technologies are mostly not used in isolation but are integrated into workflows. For instance, liquid chromatography-mass spectrometry combines the separation capabilities of liquid chromatography with the mass analysis power of mass spectrometry. This integration is particularly effective in complex sample analysis, where components need to be separated before their mass and structure can be determined. Such hybrid systems are critical in clinical settings for the high-throughput analysis of patient samples, offering a comprehensive understanding that guides diagnosis and treatment. The key applications of mass spectrometry and chromatography in diagnostics include vitamin profiling and hormone profiling, among others.
Market Introduction
The mass spectrometry and chromatography in diagnostics market is experiencing rapid growth, driven by multiple benefits offered by the technologies as compared to the traditional immunoassays, and continuous technological advancements in these technologies are further advancing their adoption. However, the high cost of acquisition of instrumentations, as well as the dearth of skilled professionals, is expected to hinder the growth of the global mass spectrometry and chromatography in diagnostics market.
Furthermore, there has been a shift toward the utilization of liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a standard technique in diagnostics. The growing preference for LC-MS/MS in diagnostics is driven by its unparalleled analytical advantages, which include exceptional specificity, sensitivity, and the ability to conduct multiplex testing, qualities that are indispensable for complex diagnostic tasks. In addition to this, the integration of automated sample preparation systems in mass spectrometry-based diagnostics marks a pivotal advancement in clinical laboratory operations. This trend will continue to expand, driven by the increasing demands for faster, more accurate diagnostic testing and the ongoing advancements in technology.
Industrial Impact
This technology has a pivotal role in diagnostics applications such as therapeutic drug monitoring, vitamin analysis, hormone profiling, newborn screening, and infectious diseases, among others.
Market Segmentation:
Segmentation 1: by Product Type
• Sample Preparation
• Mass Spectrometry and Chromatography
Mass Spectrometry and Chromatography Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type)
The mass spectrometry and chromatography segment is poised to dominate the mass spectrometry and chromatography in diagnostics market based on product type. This dominance has been driven by the high cost of the instrumentations of mass spectrometry and chromatography and the recurring use of consumables in diagnostics.
Segmentation 2: by Application Type
• Therapeutic Drug Monitoring
• Vitamins
• Hormones
• Methylmalonic Acid
• Immunosuppressants
• Others
Others Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type)
The others segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by application type. This predominance is largely due to the fact that newborn screening was one of the earliest applications of mass spectrometry and chromatography in diagnostics. These technologies have been integral to this field for a long time, making a significant contribution to the market.
Segmentation 3: by Sample Type
• Blood
• Urine
• Serum
• Plasma
• Saliva
Serum to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type)
The serum segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market based on sample type due to its suitability for a broad spectrum of applications, from hormone profiling to vitamin analysis. This makes serum an ideal sample type for precise and comprehensive diagnostic tests.
Segmentation 4: by Testing Type
• Laboratory-Developed Tests
• Commercial Assays
Laboratory-Developed Tests to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type)
The laboratory-developed tests segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by testing type. On the other hand, the commercial assay segment is expected to be the fastest-growing segment, with a CAGR of 10.40% in the forecast period 2024-2033.
Segmentation 6: by Region
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o Spain
o Italy
o France
o Rest-of-Europe
• Asia-Pacific
o China
o Japan
o India
o Rest-of-Asia-Pacific
• Latin America
o Brazil
o Mexico
o Rest-of-Latin America
• Middle East and Africa
o GCC Countries
o South Africa
o Rest-of-Middle East and Africa
The global mass spectrometry and chromatography in diagnostics market (by region) has been dominated by North America, which held 45.10% of the market share in 2023 and is anticipated to retain its position in the market during the forecast period. The region boasts an advanced healthcare infrastructure, particularly in the U.S., which facilitates the adoption of cutting-edge medical technologies, including mass spectrometry and chromatography. Additionally, North America is the hub to many leading companies in the mass spectrometry and chromatography in diagnostics market, such as Agilent Technologies, Inc., Thermo Fisher Scientific Inc., and SCIEX (Danaher Corporation), among others whose strong presence and continuous innovation drive growth of the mass spectrometry and chromatography in diagnostics market.
Recent Developments in the Mass Spectrometry and Chromatography in Diagnostics Market
• In June 2024, Shimadzu Corporation introduced the new LCMS RX series of triple quadrupole mass spectrometry instruments.
• In October 2023, Revvity, Inc. announced a value-added distribution agreement with SCIEX. This strategic agreement was aimed at enhancing Revvity's newborn screening products by integrating SCIEX’s innovative mass spectrometry solutions, leveraging expertise and resources from both companies.
• In August 2023, Thermo Fisher Scientific commercially launched the EXENT Solution upon receiving IVDR certification. This fully automated, integrated mass spectrometry system is designed to revolutionize the diagnosis and evaluation of patients suffering from monoclonal gammopathies, including multiple myeloma.
• In April 2023, Waters Corporation unveiled its next-generation Xevo TQ Absolute IVD mass spectrometer, expanding its MassTrak IVD LC-MS/MS Systems family for clinical diagnostic applications.
• In June 2022, PerkinElmer launched the GC 2400 Platform, an advanced, automated gas chromatography (GC), headspace sampler, and GC/mass spectrometry (GC/MS) solution designed to help lab teams simplify lab operations, drive precise results, and perform more flexible monitoring.
Demand – Drivers, Challenges, and Opportunities
Market Demand Drivers:
Shift from Traditional Methods to Mass Spectrometry and Chromatography in Clinical Diagnostics: The growing shift toward mass spectrometry and chromatography in clinical diagnostics represents a significant growth opportunity for the global mass spectrometry and chromatography in diagnostics market. As laboratories increasingly recognize the limitations of traditional immunoassays, the demand for more precise and efficient diagnostic technologies such as LC-MS/MS is expected to expand even more. This trend has been supported by the technology's ability to deliver accurate, robust, and cost-efficient results, which is crucial for improving patient outcomes and operational efficiency in clinical settings.
Market Challenges:
High Initial Set-Up Cost: The substantial upfront and recurring costs associated with mass spectrometry and chromatography systems present a formidable challenge for their broader adoption in clinical diagnostics. These financial barriers are particularly impactful for smaller laboratories and healthcare facilities with tight budgets, limiting their ability to invest in advanced diagnostic technologies.
Market Opportunities:
Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics: The global mass spectrometry and chromatography in diagnostics market presents substantial opportunities for growth in emerging countries, particularly through strategic focus on market expansion, growth opportunities in emerging economies, and the development of customized solutions. By focusing on affordability and accessibility, developing local partnerships and training programs, navigating regulatory requirements, and creating integrated diagnostic solutions, companies can unlock significant growth opportunities in the untapped markets of emerging countries.
Analyst’s Thoughts
According to Swati Sood, Principal Analyst – BIS Research, “The growth of the mass spectrometry and chromatography in diagnostics market is primarily driven by several benefits offered by mass spectrometry and chromatography technologies over traditional immunoassay-based methods in various applications such as newborn screening, vitamin analysis, and therapeutic drug monitoring, among others. However, high cost associated with initial set-up as well as dearth of skilled professionals is expected to restraint the growth of the global mass spectrometry and chromatography in diagnostics market.”
Mass Spectrometry and Chromatography in Diagnostics Market - A Global and Regional Analysis
Focus on Product Type, Application Type, Sample Type, Testing Type, and Region - Analysis and Forecast, 2024-2033
Some Faq's
Frequently Asked Questions
Ans: The mass spectrometry (MS) and chromatography markets are critical components of the broader analytical and life sciences instrumentation sector. Both technologies offer sophisticated methods for the separation, identification, and quantification of chemical and biological substances and have been instrumental in driving advances across a variety of fields, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, among others. Mostly, these technologies are not used in isolation and are integrated into diagnostic workflows. For instance, liquid chromatography-mass spectrometry combines the separation capabilities of liquid chromatography with the mass analysis power of mass spectrometry. This integration is particularly effective in complex sample analysis, where components need to be separated before their mass and structure can be determined. Such hybrid systems are critical in clinical settings for the high-throughput analysis of patient samples, offering a comprehensive understanding that guides diagnosis and treatment. The key applications of mass spectrometry and chromatography in diagnostics include vitamin profiling and hormone profiling, among others.
Ans: Existing market players in the mass spectrometry and chromatography in diagnostics industry are adopting various new strategies to strengthen their market position. One prominent strategy is the introduction of new products to expand their existing product line to further cater to the needs of diagnostics applications within the mass spectrometry and chromatography industry. This allows them to cater to diverse consumer needs and preferences, capturing a larger share of the market.
Ans: The following are the USPs of this report:
• Market regulations and a list of key trends in mass spectrometry and chromatography in diagnostics market
• A company competition matrix to understand the positioning of the key players
• Market dynamic analysis of the opportunities, trends, and challenges in the market
Ans: Well-established manufacturers and emerging players involved in mass spectrometry and chromatography can use the report to assess market trends, identify opportunities for product development, and refine marketing strategies. Retailers can gain insights into consumer preferences and market dynamics to optimize their product offerings and distribution channels. Investors and financial analysts can leverage the report to evaluate the market's growth potential, assess investment opportunities, and make informed decisions.
Similar Product
You may also like
Published Year: 2024
High-Performance Liquid Chromatography Market - A Global and Regional Analysis: Focus on Application
The global HPLC market was estimated at $5.23 billion in 2023 and is expected to reach $8.22...